Real-world data on effectiveness, safety, and other outcomes are increasingly being demanded by multiple stakeholders. Data can be obtained using secondary data sources (electronic medical records, claims/administrative data, existing registries) or through primary de novo data collection.
Dr. Annette Stemhagen, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, and Dr. Robert Sharrar, Executive Director, Safety, Epidemiology, Registries and Risk Management, led an informative tutorial on pharmacoepidemiology this week at the DIA Pharmacovigilance and Risk Management conference.
UBC scientists never stop learning. And, they never stop sharing what they’ve learned. As healthcare professionals committed to improving patient outcomes, our scientists often use their research and studies for teaching opportunities.
Congratulations to three of our clinical experts whose abstracts were selected for the upcoming ICPE conference.